<DOC>
	<DOCNO>NCT00502229</DOCNO>
	<brief_summary>Several data demonstrate clomiphene citrate ( CC ) metformin two safe valid first-step option induce ovulation infertile anovulatory PCOS patient . Notwithstanding high percentage patient ovulate treatment , ~40 % 60 % subject obtain pregnancy CC metformin , respectively . For patient , control ovarian stimulation ( COS ) follow intrauterine insemination ( IUI ) could next therapeutic step assist reproductive technique since IUI improve significantly fertility couple unexplained infertility . Furthermore , date define COS obtain use ovulatory agent ( CC metformin ) switch treatment gonadotropin . In view , aim present study evaluate best management infertile PCOS patient ovulate CC metformin .</brief_summary>
	<brief_title>Therapy Infertile PCOS Patients Ovulating Under Clomiphene Citrate Metformin</brief_title>
	<detailed_description>Infertile PCOS patient ovulate CC metformin without pregnancy achievement enrol treat three trial COS plus IUI . All patient randomly allocate two different group ( group A B ) . In group A , COS obtain use ovulatory agent ( CC metformin ) employ previous ovulatory cycle , whereas group B use gonadotropin low-dose step-up regimen . All patient eligible undergo baseline assessment consist anthropometric , hormonal , ultrasonographic evaluation . During study , clinical reproductive outcome , adverse experience evaluate analyze also categorize patient accord ovulatory agent use COS ( CC metformin ) . Data analyze use intention-to-treat principle P value 0.05 less consider significant . Continuous variable analyze unpaired test general linear model repeat measure analysis Bonferroni test post-hoc analysis require . For categorical variable , Pearson chi-square Fisher 's exact test use . Cumulative pregnancy rate , primary end-point , calculate Kaplan-Maier method , difference two group assess log-rank test . Cox proportional-hazards model use calculate hazard ratio new pregnancy group .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Polycystic ovary syndrome ( use NIH criterion ) Anovulatory infertility ( use WHO criterion ) Age &lt; 18 &gt; 35 year Severe obesity ( BMI &gt; 35 ) Neoplastic , metabolic , hepatic , cardiovascular disorder concurrent medical illness Hypothyroidism , hyperprolactinemia , Cushing 's syndrome , nonclassical congenital adrenal hyperplasia Current previous ( within last six month ) use oral contraceptive , glucocorticoid , antiandrogens , antidiabetic antiobesity drug hormonal drug Intention start diet specific program physical activity Organic pelvic diseases Previous pelvic surgery Suspected peritoneal factor infertility Tubal male factor infertility subfertility</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Clomiphene citrate</keyword>
	<keyword>Controlled overian stimulation</keyword>
	<keyword>Infertility</keyword>
	<keyword>Metformin</keyword>
	<keyword>Polycystic ovary syndrome</keyword>
	<keyword>Treatment</keyword>
</DOC>